期刊文献+

2型糖尿病大鼠并发心肌病的研究 被引量:5

Study on cardiomyopathy complicated with type 2 diabetes mellitus in rats
原文传递
导出
摘要 目的 在大鼠中复制类似人类2型糖尿病模型,观察并发糖尿病性心肌病的情况.方法 取健康雄性SD大鼠120只,体质量180~220 g,按体质量及血糖值分为4组:(1)糖尿病组:40只,高糖高脂饲料喂养,一次性腹腔注射30 mg/kg链脲佐菌素(STZ)溶液 (2)STZ组:30只,普通饲料喂养,一次性腹腔注射30 mg/kg STZ溶液 (3)高糖高脂饲料组:25只,高糖高脂饲料喂养,一次性腹腔注射等容积柠檬酸盐缓冲液溶液 (4)对照组:25只,普通饲料喂养,一次性腹腔注射等容积柠檬酸盐缓冲液溶液.腹腔注射STZ溶液或柠檬酸盐缓冲液溶液后,观察动物饮水、进食及尿量变化.注射后4、8、12、16周,各组分批抽样检查,称取体质量,取血检测空腹血糖、空腹胰岛素、三酰甘油、总胆固醇 处死动物取心脏称质量,取心肌组织行光镜及透射电镜观察.结果 实验饲料喂养1周,各组大鼠体质量、血糖差异无统计学意义(P〉0.05) 喂养4周,STZ或柠檬酸盐缓冲液注射前,糖尿病组和高糖高脂饲料组大鼠体质量、空腹胰岛素、胰岛素抵抗指数较对照组和STZ组明显升高(P〈0.05) 糖尿病组与高糖高脂饲料组相比、STZ组和对照组相比差异均无统计学意义(P〉0.05).注射后4个时段,糖尿病组和高糖高脂饲料组大鼠血糖、体质量、心脏质量、血三酰甘油、总胆固醇比同时段的对照组和STZ组增高(P〈0.05),糖尿病组大鼠的上述指标较高糖高脂饲料组大鼠增加更显著,差异有统计学意义(P〈0.05),STZ组和对照组相比差异无统计学意义(P〉0.05).心肌光镜和电镜检查结果显示,糖尿病组大鼠心肌细胞肥厚并出现变性、凋亡等显著病变,间质胶原纤维增生 STZ组大鼠心肌无明显病理改变 高糖高脂饲料组大鼠心肌呈现类似糖尿病大鼠病理改变,但与糖尿病组大鼠相比,改变较不明显.结论 2型糖尿病大鼠成模4周后,心脏发生糖尿病性心肌病的病理改变,表现为心肌细胞肥大、变性,间质纤维组织增生,其发生率为100%. Objective To study the development of cardiomyopathy complicated with type 2 diabetes mellitus in the rats. Methods The 120 health male Sprague-Dawley rats, weighing 180-220 g, were divided into 4 groups: (1)STZ-modeled diabetes, fed with high-carbohydrate plus high-fat diet (n=40) (2)fed with regular diet (n=30) (3)and (4)SD rats with citrate buffer instead of STZ injection, fed with high-carbohydrate and high fat diet (n= 25) and fed with regular diet (n= 25) At the 4th, 8 th, 12 th and 16 th week after the intra-peritoneal injection of STZ solution or citrate buffer solution, rats from each group were scarified and examined. Results There were no significant differences in body mass and blood glucose among those groups after one week of feeding (P〉0. 05).After 4 weeks of feeding before injection, the body mass, fasting insulin (FINS) and insulin sensitive index (ISI) were obviously increased in diabetes group and high-carbohydrate plus high-fat control group as compared with STZ control group and normal control group (P〈 0. 05). There were no significant differences between diabetes group and high-carbohydrate plus high-fat control group,between STZ control group and normal control group (P〉0. 05). After injection, the blood glucose,body mass, ventricular mass, TG and TC were higher in diabetes group and high-carbohydrate plus high-lipid control group than in STZ control group and normal control group (P〈0.05). The above parameters were much higher in diabetes group than in high-carbohydrate plus high-lipid control group, but there was no difference between STZ control group and normal control group (P〈0. 05).Pathological examination showed that the weight of the heart was significantly increased, the myocardial cells were hypertrophied accompanying degenerative changes and apoptosis, the interstitial collagen fibers were hyperplasia in the diabetic rats. The ultrastructures also presented severe damage.These changes indicated that cardiomyopathy was induced in the diabetes rats. Although similar changes were found in the rats fed with high-carbohydrate plus high-fat diet, they were much less significant than those in the diabetic rats. Conclusions Cardiomyopathy developes frequently in the rats with type 2 diabetes mellitus induced by feeding high-carbohydrate plus high-lipid diet and single intra-peritonial injection of 30 mg/kg STZ solution.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2010年第9期770-775,共6页 Chinese Journal of Geriatrics
基金 基金项目:贵州省省长基金[黔省专合字(2009)41号]
关键词 糖尿病 2型 心肌疾病 动物实验 Diabetes mellitus,type 2 Cardiomyopathies Animal experimentation
  • 相关文献

参考文献10

二级参考文献46

  • 1文重远,刘永明,王腾,张平安,陈小琳,李庚山.罗格列酮对2型糖尿病心肌能量底物代谢的影响[J].中国病理生理杂志,2005,21(6):1081-1084. 被引量:8
  • 2宋君秋,刘艳霞.雷米普利对大鼠缺血/再灌注心肌细胞凋亡及凋亡相关基因表达的影响[J].中国药理学通报,2006,22(5):625-628. 被引量:12
  • 3Lindholm LH, Ibsen H, Borch-Johnsen K, et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens, 2002, 20 : 1879-1886.
  • 4Sever P. The VALUE trial: a commentary. J Renin Angiotensin Aldosterone Syst, 2004, 5:99-101.
  • 5Thurman JM, Schrier RW. Comparative effects of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney. Am J Med, 2003, 114:588-598.
  • 6Naito T, Masaki T, Nikolic-Paterson DJ, et al. Angiotensin Ⅱ induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol, 2004, 286 :F278-287.
  • 7Tokudome T, Horio T, Yoshihara F, et al. Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. Metabolism,2004, 53:710-715.
  • 8Neumann S, Huse K, Semrau R, et al. Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension, 2002, 39:756-760.
  • 9Gray MO, Long CS, Kalinyak JE, et al. Angiotensin Ⅱ stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res, 1998, 40:352-363.
  • 10Okoshi K, Guimaraes JF, Di Muzio BP, et al. Diabetic cardiomyopathy. Arq Bras Endocrinol Metabol, 2007, 51: 160- 167.

共引文献337

同被引文献64

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部